What does DOKTER JAN VAN DEN SAFFELE do?

DOKTER JAN VAN DEN SAFFELE is a specialist medical practice in Roeselare. Private Limited, started on 6 November 2007, 1 establishment.

What is the address of DOKTER JAN VAN DEN SAFFELE?

The registered office of DOKTER JAN VAN DEN SAFFELE is located at Brugsesteenweg 167, 8800 Roeselare.

Is DOKTER JAN VAN DEN SAFFELE still active?

Yes. According to the CBE (30 October 2026) DOKTER JAN VAN DEN SAFFELE is active, legal situation “Normale toestand”, started on 6 November 2007.

Is DOKTER JAN VAN DEN SAFFELE registered on Peppol?

Yes, DOKTER JAN VAN DEN SAFFELE is registered on the Peppol network with ID 0208:0893322686.

What is the enterprise number of DOKTER JAN VAN DEN SAFFELE?

The enterprise number of DOKTER JAN VAN DEN SAFFELE is BE0893322686.

When was DOKTER JAN VAN DEN SAFFELE founded?

DOKTER JAN VAN DEN SAFFELE was founded on 6 November 2007.

Who are the directors of DOKTER JAN VAN DEN SAFFELE?

According to the 2025 annual accounts, the directors of DOKTER JAN VAN DEN SAFFELE are: JAN VAN DEN SAFFELE.

Is DOKTER JAN VAN DEN SAFFELE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER JAN VAN DEN SAFFELE make in 2025?

DOKTER JAN VAN DEN SAFFELE posted a profit after taxes of € 43,007 in financial year 2025.

What is the revenue of DOKTER JAN VAN DEN SAFFELE?

As a small company, DOKTER JAN VAN DEN SAFFELE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 66,591.

DOKTER JAN VAN DEN SAFFELE (Private Limited) - Roeselare

Dossier DOKTER JAN VAN DEN SAFFELE, printed on 30 October 2026 from databakkes.be/en/0893322686/dokter-jan-van-den-saffele. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER JAN VAN DEN SAFFELE from Roeselare, company number BE0893322686, closed financial year 2025 with a result of € 43,007 after tax. For that financial year DOKTER JAN VAN DEN SAFFELE recorded a gross margin of € 66,591 and equity of € 441,912. Compared with financial year 2024, the result moved from € 73,883 to € 43,007. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 441,912

▼ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 43,007

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 232,673

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 212,162 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 701

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 54,022

▲ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,618 Gross margin 2022: € 70,618 First fiscal year in the series	€ 24,226 Gross margin 2023: € 24,226 ▼ 66% vs 2022 (€ 70,618) Unfavourable step	€ 126,077 Gross margin 2024: € 126,077 ▲ € 101,851 vs 2023 (€ 24,226) Favourable step	€ 66,591 Gross margin 2025: € 66,591 ▼ 47% vs 2024 (€ 126,077) Unfavourable step	▼ 47%
Profit after taxes	€ 63,916 Profit after taxes 2022: € 63,916 First fiscal year in the series	€ 179 Profit after taxes 2023: € 179 ▼ € 63,737 vs 2022 (€ 63,916) Unfavourable step	€ 73,883 Profit after taxes 2024: € 73,883 ▲ € 73,703 vs 2023 (€ 179) Favourable step	€ 43,007 Profit after taxes 2025: € 43,007 ▼ 42% vs 2024 (€ 73,883) Unfavourable step	▼ 42%
Equity	€ 530,806 Equity 2022: € 530,806 First fiscal year in the series	€ 537,185 Equity 2023: € 537,185 ▲ 1% vs 2022 (€ 530,806) Favourable step	€ 611,068 Equity 2024: € 611,068 ▲ 14% vs 2023 (€ 537,185) Favourable step	€ 441,912 Equity 2025: € 441,912 ▼ 28% vs 2024 (€ 611,068) Unfavourable step	▼ 28%
Total debts	€ 22,544 Total debts 2022: € 22,544 First fiscal year in the series	€ 6,212 Total debts 2023: € 6,212 ▼ 72% vs 2022 (€ 22,544) Favourable step	€ 36,700 Total debts 2024: € 36,700 ▲ € 30,488 vs 2023 (€ 6,212) Unfavourable step	€ 54,883 Total debts 2025: € 54,883 ▲ 50% vs 2024 (€ 36,700) Unfavourable step	▲ 50%
Cash	€ 280,315 Cash 2022: € 280,315 First fiscal year in the series	€ 188,017 Cash 2023: € 188,017 ▼ 33% vs 2022 (€ 280,315) Unfavourable step	€ 259,054 Cash 2024: € 259,054 ▲ 38% vs 2023 (€ 188,017) Favourable step	€ 232,673 Cash 2025: € 232,673 ▼ 10% vs 2024 (€ 259,054) Unfavourable step	▼ 10%
Land & buildings	€ 16,478 Land & buildings 2022: € 16,478 First fiscal year in the series	€ 15,503 Land & buildings 2023: € 15,503 ▼ 6% vs 2022 (€ 16,478) Unchanged	€ 13,337 Land & buildings 2024: € 13,337 ▼ 14% vs 2023 (€ 15,503) Unchanged	€ 12,362 Land & buildings 2025: € 12,362 ▼ 7% vs 2024 (€ 13,337) Unchanged	▼ 7%
Retained profit	€ 518,406 Retained profit 2022: € 518,406 First fiscal year in the series	€ 518,585 Retained profit 2023: € 518,585 Unchanged (€ 518,406) Favourable step	€ 592,468 Retained profit 2024: € 592,468 ▲ 14% vs 2023 (€ 518,585) Favourable step	€ 423,312 Retained profit 2025: € 423,312 ▼ 29% vs 2024 (€ 592,468) Unfavourable step	▼ 29%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 212,162 Dividend 2025: € 212,162 Unchanged (€ 0) Unchanged
Balance sheet total	€ 553,350 Balance sheet total 2022: € 553,350 First fiscal year in the series	€ 543,397 Balance sheet total 2023: € 543,397 ▼ 2% vs 2022 (€ 553,350) Unchanged	€ 647,768 Balance sheet total 2024: € 647,768 ▲ 19% vs 2023 (€ 543,397) Unchanged	€ 496,796 Balance sheet total 2025: € 496,796 ▼ 23% vs 2024 (€ 647,768) Unchanged	▼ 23%

Key figures of DOKTER JAN VAN DEN SAFFELE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER JAN VAN DEN SAFFELE?

What happened at DOKTER JAN VAN DEN SAFFELE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 43,007 (▼ 42% vs 2024). filed late Source: NBB ↗
Nov 6, 2007 New establishment in Roeselare. KBO
Nov 6, 2007 Start of the company according to the CBE. KBO

In short

From € 63,916 profit in 2022 to € 43,007 profit in 2025.

Paid € 101,205 in corporate taxes since 2022.

Best year ever: 2024, with € 73,883 profit.

Paid out € 212,162 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JAN VAN DEN SAFFELE

DOKTER JAN VAN DEN SAFFELE

HASHIMOTO

Behind DOKTER JAN VAN DEN SAFFELE is JAN VAN DEN SAFFELE. JAN VAN DEN SAFFELE is also behind HASHIMOTO.

Directors

According to the 2025 annual accounts

JAN VAN DEN SAFFELE

Director

Also active at: HASHIMOTO

Establishments

Establishment units

Physical locations of this company

Registered office

Brugsesteenweg 167

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0893.322.686
VAT number: BE 0893.322.686
Registered office: Brugsesteenweg 167, 8800 Roeselare
Names & denominations: DOKTER JAN VAN DEN SAFFELE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2007
Peppol: Active · Active since 6 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗